Stay updated on NivolumabIpilimumabComboInBreastOvarianGastricClinicalTrial
Sign up to get notified when there's something new on the NivolumabIpilimumabComboInBreastOvarianGastricClinicalTrial page.

Latest updates to the NivolumabIpilimumabComboInBreastOvarianGastricClinicalTrial page
- Check7 days agoChange DetectedGastric cancer is now listed as a condition in the study details, and the Genetic and Rare Diseases Information Center has been added as a Resources link. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision: v3.4.2 is now displayed. The funding-status notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site notice about a lapse in funding and NIH Clinical Center status, and updated the page revision to v3.4.1 by replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now includes a glossary display and shows a new 'Last Update Submitted that Met QC Criteria' field, and updates the footer to 'No FEAR Act Data' with a new revision label 'Revision: v3.4.0'. The previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a Locations section with New York as a site and removed the old New York Locations footer entry; page revision updated to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to NivolumabIpilimumabComboInBreastOvarianGastricClinicalTrial
Enter your email address, and we'll notify you when there's something new on the NivolumabIpilimumabComboInBreastOvarianGastricClinicalTrial page.